Takashi Maoka Selected Research

Takashi Maoka Research Topics

Disease

11	Neoplasms (Cancer) 05/2013 - 12/2002
4	Inflammation (Inflammations) 12/2021 - 01/2013
2	Insulin Resistance 12/2021 - 01/2013
2	Obesity 01/2021 - 01/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2018 - 01/2013
2	Leukemia 05/2011 - 07/2008
2	Type 2 Diabetes Mellitus (MODY) 04/2008 - 01/2004
2	Diabetic Nephropathies (Diabetic Nephropathy) 04/2008 - 01/2004
1	Non-alcoholic Fatty Liver Disease 12/2021
1	Glioblastoma (Glioblastoma Multiforme) 09/2020
1	Overweight 09/2018
1	Atopic Dermatitis (Atopic Eczema) 01/2016
1	Dermatitis 01/2016
1	Pruritus (Itching) 01/2016
1	Skin Diseases (Skin Disease) 01/2016
1	Progressive Multifocal Leukoencephalopathy 01/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2015
1	Breast Neoplasms (Breast Cancer) 05/2013
1	Papilloma (Papillomatosis) 06/2012
1	Lung Neoplasms (Lung Cancer) 02/2012
1	Lymphoma (Lymphomas) 02/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2011
1	Infections 11/2010
1	Melanoma (Melanoma, Malignant) 09/2010
1	Experimental Melanoma 09/2010
1	Hyperglycemia 04/2008
1	Colonic Neoplasms (Colon Cancer) 06/2007
1	Myeloid Leukemia (Leukemia, Myelocytic) 03/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2004
1	Body Weight (Weight, Body) 01/2004
1	Parasitemia 04/2002

Drug/Important Bio-Agent (IBA)

10	Carotenoids (Carotene)IBA 12/2021 - 07/2004
6	astaxanthine (astaxanthin)IBA 09/2020 - 01/2004
5	Epstein-Barr virus early antigenIBA 05/2013 - 02/2006
2	AntioxidantsIBA 12/2021 - 09/2018
2	adonixanthinIBA 09/2020 - 01/2013
2	XanthophyllsIBA 09/2018 - 02/2012
2	CytokinesIBA 01/2016 - 04/2008
2	anthraceneIBA 01/2013 - 10/2011
1	Vitamin A (Retinol)FDA LinkGeneric 12/2021
1	ProvitaminsIBA 12/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2021
1	CryptoxanthinsIBA 12/2021
1	RetinoidsIBA 12/2021
1	Dihydrotachysterol (AT 10)IBA 09/2020
1	AllergensIBA 01/2016
1	Immunoglobulin E (IgE)IBA 01/2016
1	Mefloquine (Lariam)FDA LinkGeneric 01/2015
1	Rituximab (Mabthera)FDA Link 01/2015
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2013
1	disiloxaneIBA 05/2013
1	1,3- dimethyl- 1,3- p- fluorophenyl- 1,3- (3- morpholinopropyl)- 1,3- disiloxaneIBA 05/2013
1	1,3- dimethyl- 1,3- (4- fluorophenyl)- 1,3- (3- butyl- (1- piperazinyl)propyl)- 1,3- disiloxaneIBA 05/2013
1	MorpholinosIBA 05/2013
1	LipidsIBA 01/2013
1	adonirubinIBA 01/2013
1	AdipokinesIBA 01/2013
1	LuteinIBA 06/2012
1	Peroxynitrous Acid (Peroxynitrite)IBA 06/2012
1	capsorubinIBA 02/2012
1	Pharmaceutical PreparationsIBA 02/2012
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 02/2012
1	capsanthinIBA 02/2012
1	siphonaxanthinIBA 05/2011
1	QuinonesIBA 11/2010
1	Monophenol Monooxygenase (Tyrosinase)IBA 09/2010
1	fucoxanthinIBA 09/2010
1	Melanins (Melanin)IBA 09/2010
1	Phospholipase DIBA 07/2008
1	Monoterpenes (Monoterpenoids)IBA 07/2008
1	AlcoholsIBA 07/2008
1	Transcription Factors (Transcription Factor)IBA 04/2008
1	Glucose (Dextrose)FDA LinkGeneric 04/2008
1	LigandsIBA 06/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2007
1	halocynthiaxanthinIBA 06/2007
1	peridininIBA 06/2007
1	beta-GlucansIBA 03/2005
1	Conditioned Culture MediaIBA 03/2005
1	licheninIBA 03/2005
1	laminaranIBA 03/2005
1	Blood Glucose (Blood Sugar)IBA 01/2004
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2004
1	AlbuminsIBA 01/2004
1	dinochrome AIBA 12/2002

Therapy/Procedure

3	Therapeutics 05/2013 - 06/2007
1	Oral Administration 09/2020
1	Drug Therapy (Chemotherapy) 01/2015
1	Chemoprevention 05/2013
1	Withholding Treatment 04/2002